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ABSTRACT
The HIV-1 transactivator of transcription (Tat)
protein is thought to stimulate reverse transcription
(RTion). The Tat protein and, more specifically, its
(44–61) domain were recently shown to promote
the annealing of complementary DNA sequences
representing the HIV-1 transactivation response
element TAR, named dTAR and cTAR, that plays a
key role in RTion. Moreover, the kinetic mechanism
of the basic Tat(44–61) peptide in this annealing
further revealed that this peptide constitutes a
representative nucleic acid annealer. To further
understand the structure–activity relationships of
this highly conserved domain, we investigated by
electrophoresis and fluorescence approaches the
binding and annealing properties of various
Tat(44–61) mutants. Our data showed that the
Tyr47 and basic residues of the Tat(44–61) domain
were instrumental for binding to cTAR through
stacking and electrostatic interactions, respectively,
and promoting its annealing with dTAR. Further-
more, the annealing efficiency of the mutants
clearly correlates with their ability to rapidly associ-
ate and dissociate the complementary oligonucleo-
tides and to promote RTion. Thus, transient and
dynamic nucleic acid interactions likely constitute
a key mechanistic component of annealers and the
role of Tat in the late steps of RTion. Finally, our data
suggest that Lys50 and Lys51 acetylation regulates
Tat activity in RTion.
INTRODUCTION
The transactivator of transcription (Tat) is crucially
required for efﬁcient transcription of the integrated HIV
viral genome (1,2). Tat increases the efﬁciency of the tran-
scription complex via the recruitment of various cellular
factors on binding to the transactivating response (TAR)
element (3–5), leading to the active production of full-
length viral RNA (6–10). The sequence of Tat that
mediates speciﬁc TAR binding has been mapped to the
basic (49–57) domain composed mostly of Arg and Lys
residues (11,12), in line with the ability of arginine-rich
peptides to bind speciﬁcally to RNA (13–15). Moreover,
Tat is thought to regulate Rev-dependent mRNA trans-
port (16), mRNA capping (17), splicing (18) and transla-
tion (19), and to interfere with the cellular RNA
interference machinery through interactions with
DICER and RNA (20,21).
In addition, several lines of evidence also suggest a role
of Tat in the stimulation of reverse transcription (RTion).
HIV-1 mutants deleted of the Tat gene display a 3- to
5-fold defect in RTion compared with wild-type HIV-1
in infected T cells and in endogeneous RTion reactions
(22,23), whereas full restoration of RTion can be
achieved by transfecting the producer cells by a Tat expres-
sion plasmid. Moreover, recombinant Tat also stimulates
2- to 3-fold in vitro DNA synthesis directed by reverse
transcriptase (24). Ex vivo studies on Tat mutants further
reveal that Tat activities in RTion and transactivation are
not correlated, suggesting that Tat directly stimulates
RTion (23). The stimulatory activity of Tat in RTion is
mainly supported by its 60 ﬁrst amino acids (22), with a
critical role for the basic (49–57) domain and the Tyr47
residue of the core domain (24).
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The possible stimulatory effect of Tat in RTion within
HIV-1 virions was substantiated by the detection of Tat
in HIV-1 virions produced by macrophages (25).
Alternatively, by permeating the plasma membrane, extra-
cellular Tat could enter in newly infected cells to stimulate
RTion after disassembly of the viral core or the natural
endogeneous RTion that occurs during assembly (26–28).
Part of the stimulatory effect of Tat in RTion likely
results from its nucleic acid annealing activity. Tat can
promote the annealing of (i) the primer tRNA onto the
viral HIV-1 RNA (29), (ii) complementary viral DNA se-
quences representing the HIV-1 TAR element, named
dTAR and cTAR (30,31), (iii) the HIV-1 (±) primer
binding sequences (32) and (iv) complementary RNA
model sequences of 21 nt (33). Moreover, based on mech-
anistic studies with the three last systems, it appears that
Tat can efﬁciently promote annealing of complementary
sequences, without showing any nucleic acid destabilizing
property. Therefore, Tat does not constitute a canonical
chaperone protein, but rather belongs to the family of
nucleic acid annealers. The annealer activity of Tat is
mainly mediated through its 44–61 domain, as dem-
onstrated by the potent DNA and RNA annealing
activities of the Tat(44–61) peptide, which corresponds
to the smallest known peptide endowed with these
activities (30).
The eight basic residues of the Tat basic domain are
critical for both binding to TAR (12) and accelerating
the annealing of model complementary RNA sequences
(33). Moreover, the distribution of the basic amino acids
appears more important than their nature for the nucleic
acid annealing (33) and transactivation activities (12).
A further illustration of the importance of these basic
amino acids is that speciﬁc acetylation of Lys50 and
Lys51 residues, altering the positive charge distribution,
allows a ﬁne regulation of Tat activity (34–39).
Interestingly, mutation of the aromatic Tyr47 residue
induces only limited defects in transactivation, but
strongly delays replication (40,41), probably as a result
of a RTion defect (24,42). A further difference in the struc-
ture–activity relationship of the roles of Tat in transacti-
vation and RTion is that only the former correlates with
the nucleic acid binding afﬁnity of Tat mutants (12,24,33).
In this context, to further delineate the relationship
between the amino acid sequence of the Tat(44–61)
domain and its nucleic acid annealing activity in RTion,
we investigated by ﬂuorescence techniques and gel electro-
phoresis the binding and annealing activities of various
mutants of the Tat(44–61) peptide on the complementary
cTAR and dTAR DNA sequences involved in RTion
(Figure 1). The binding of Tat(44–61) to cTAR DNA
appears largely governed by electrostatic interactions
with the basic residues, and further stabilized by the
stacking of the Tyr47 residue with the cTAR bases.
Though all the tested peptides promoted cTAR/dTAR
annealing, our data clearly evidenced that their efﬁciency
is associated with their ability to rapidly associate and
dissociate the intermediate cTAR/dTAR complex that nu-
cleates the ﬁnal cTAR/dTAR duplex. Moreover, compari-
son of our data with the literature further highlighted a
good correlation between the ability of the Tat-mutated
peptides to induce transient and dynamic interactions
between the peptide-coated nucleic acids and the efﬁciency
in RTion of the corresponding mutations in Tat. Thus,
promotion of transient and dynamic nucleic acid inter-
actions likely constitutes a key mechanistic component
of the role of Tat in RTion and for nucleic acid annealers,
in general. Finally, our data further suggest that acetyl-
ation of Lys50 and Lys51 residues may regulate Tat
activity in RTion.
MATERIALS AND METHODS
Tat(44–61), its truncated forms Tat(50–61) and Tat(44–
57), its mutants Tat(44–61)R52A R53A, Tat(44–
61)R55A R56A, Tat(44–61)Y47A, Tat(44–61)Q54A and
the 50, 51o-acyl-Lys form of Tat(44–61) [Tat(44–61)ac]
were synthesized by solid-phase peptide synthesis on a
433A synthesizer (ABI, Foster City, CA, USA) and
puriﬁed by HPLC (43). The peptides were stored
lyophilized. Their purity was >98% as judged from the
HPLC elution proﬁles. The concentration of Tat(44–61),
Tat(44–57), Tat(44–61)R52A R53A, Tat(44–61)R55A
R56A, Tat(44–61)ac and Tat(44–61)Q54A was measured
using an extinction coefﬁcient at 280 nm of
1300M1cm1. The concentration of Tat(44–61)Y47W
was measured using an extinction coefﬁcient at 280 nm
of 5400M1 cm1. The concentration of Tat(50–61)
and Tat(44–61)Y47A was calculated from the absorb-
ance of the peptide solutions at 214 nm as described in
reference (44). Unless otherwise mentioned, experiments
were done in freshly prepared and degassed 25mM Tris
buffer (pH 7.5) containing 30mM NaCl and 0.2mM
MgCl2.
The oligodeoxynucleotides corresponding to sense and
anti-sense HIV-1 TAR and oligodeoxynucleotides select-
ively labeled at different positions with 20-deoxyribosyl-2-
aminopurine (2-Ap) were purchased from IBA GmbH
Nucleic Acids Product Supply (Go¨ttingen, Germany).
Doubly labeled cTAR was modiﬁed at its 50 terminus
with 5 (and-6) carboxytetramethylrhodamine (TMR)
and at its 30 terminus with 5 (and 6)-carboxyﬂuorescein
(Fl), via an amino-linker with a six carbon spacer arm.
The oligonucleotides were puriﬁed by the manufacturer
by reverse-phase HPLC and polyacrylamide gel electro-
phoresis. An extinction coefﬁcient at 260 nm of
515 070M1 cm1 was used to calculate the concentra-
tions of cTAR and dTAR.
For gel electrophoresis experiments, cTAR and dTAR
DNAs were 50-end labeled using T4 polynucleotide kinase
(New England Biolabs, Ipswich, MA) and [g-32P] ATP
(Perkin Elmer, Waltham, MA). For the footprinting ex-
periments, the cTAR DNA was labeled at the 30-end with
[a-32P] dATP (Perkin Elmer, Waltham, MA) and Taq
DNA polymerase (New England Biolabs, Ipswich, MA),
as described previously (45). The 32 P-labeled nucleic acids
were puriﬁed by electrophoresis on a 12% denaturing
polyacrylamide gel and isolated by elution followed by
ethanol precipitation.
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Investigating the TAR/peptide interactions
Fluorescence monitoring of the peptide binding to cTAR
Equilibrium binding experiments aimed at determining the
apparent association constant, Kobs, of the complexes
between cTAR and Tat peptides were performed by
adding small aliquots (2.5–5 ml) of the peptide stock
solution to 10 nM cTAR-30-Fl. Steady-state ﬂuorescence
anisotropy (with excitation at 480 nm) of each data point
was monitored at 20C using a T-format SLM 8000
spectroﬂuorometer equipped with a thermostated cell
holder. A home-made device ensured the automatic
rotation of the excitation polarizer. The light emitted by
the reaction mixture was monitored through high-pass
ﬁlters (Kodak, 520 nm). The best estimate of Kobs was
obtained by ﬁtting the ﬂuorescence data to Equation (1)
(30), which assumes that one molecule of cTAR can bind n
molecules of peptide on independent and equivalent
binding sites:
S ¼ S0+St  S0
nNt

1+Pt+nNtð ÞKobs 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1+Pt+nNtð ÞKobsð Þ24PtnNtK2obs
q
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0
@
1
A
ð1Þ
where So and St are the initial and ﬁnal anisotropy, re-
spectively, Nt the oligonucleotide concentration and Pt the
protein concentration. The value of n was determined to
be 10 for the cTAR/Tat(44–61) interaction (30), which
corresponds to an occluded binding site of 5.5 nt per
peptide. This stoichiometry was used to calculate the
Kobs values for all the complexes studied here. The salt
dependence of the binding constants was determined
from titrations performed at salt concentrations, varying
from 30 to 150mM NaCl.
Gel retardation assays
Assays were carried out in a ﬁnal volume of 10 ml. The
50-end labeled cTAR DNA (2.5 pmol) at 8 103 cpm/pmol
was dissolved in 6 ml of water, heated at 90C for 2min
and chilled for 2min on ice. Then, 2 ml of renaturation
buffer was added [ﬁnal concentrations: 30mM NaCl,
0.2mM MgCl2 and 25mM Tris–HCl (pH 7.5)] and the
sample was incubated for 15min at 20C in the absence
or presence of peptide at various concentrations. Gel
loading buffer (ﬁnal concentrations: 10% w/v glycerol,
0.01% w/v bromophenol blue, 0.01% w/v xylene cyanol)
was added and the samples were analyzed by electrophor-
esis on a 10% polyacrylamide gel (Acrylamide:Bis-
acrylamide=29:1) at 4C in 0.5TBE buffer [45mM
Tris-borate (pH 8.3), 1mM EDTA]. After electrophoresis,
the gel was ﬁxed, dried and autoradiographed.
Footprinting assays
Mung bean (MB) nuclease and DNase I were purchased
from New England Biolabs (Ipswich, MA) and Promega
(Madison, WI), respectively. Structural probing of cTAR
DNA was carried out in a ﬁnal volume of 10 ml. The
30-end labeled cTAR DNA (2.5 pmol at 2104 cpm/
pmol) in 5.5 ml of water was heated at 90C for 2min
and chilled for 2min on ice. Then, 2.5 ml of renaturation
buffer (ﬁnal concentrations: 30mM NaCl, 0.2mM MgCl2
and 25mM Tris-HCl pH 7.5 for probing with DNase I;
30mM NaCl, 0.2mM MgCl2 and 50mM sodium
Figure 1. Sequences of the peptides and oligonucleotides used.
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cacodylate pH 6.5 for probing with MB nuclease) were
added and the sample was incubated for 15min at 20C
in the absence or presence of peptide at various concen-
trations. The samples were then incubated with either 2
units of MB nuclease for 15min at 20C or 0.1 unit of
DNase I for 7min at 20C. The cleavage reactions were
stopped by phenol-chloroform extraction followed by
ethanol precipitation. The dried pellets were resuspended
in 10 ml of loading buffer (7M urea, 0.03 w/v%
bromophenol blue and 0.03 w/v% xylene cyanol). The
G, G+A and T+C sequence markers of the labeled
cTAR were produced by the Maxam–Gilbert method
(46). To identify all cleavage sites at the nucleotide level,
the samples were analyzed by electrophoresis on
denaturing 14% polyacrylamide gels using short and
long migration times.
Investigating the kinetics of the cTAR/dTAR annealing
reaction
The kinetics of cTAR/dTAR annealing was investigated
at 20 C under pseudo ﬁrst-order conditions by reacting
10 nM doubly labeled cTAR with, at least, a 10-fold
higher concentration of unlabeled dTAR (30,31,47) in
the presence of Tat(44–61) or one of its derivative added
to a molar ratio of three peptides per oligonucleotide. The
reaction was triggered by mixing 400ml of a solution of
dTAR and peptide with the same volume of a solution of
TMR-5’-cTAR-30-Fl and peptide, a process that avoids
aggregation resulting from local high concentration of
reagents. The annealing process was followed by continu-
ously monitoring the Fl ﬂuorescence intensity at 520 nm
(with excitation at 480 nm). All reported concentrations of
the reagents correspond to those after mixing. Emission
spectra and kinetic traces were recorded with a Fluoro-
Max 3 spectroﬂuorometer (Jobin Yvon Instruments)
equipped with a thermostated cell holder. All ﬂuorescence
intensities were corrected for buffer emission and lamp
ﬂuctuations.
Non-linear least square ﬁts were performed with the
Levenberg–Marquardt algorithm using the Origin
software (Microcal). Numerical resolution of the kinetic
parameters was performed by ﬁtting simultaneously the
set of progress curves with the Dynaﬁt software (BioKin
Ltd.) (48). Numerical tests (Kolmogorov, Durbin–
Wattson, Tukey statistics) and the reduced 2 values
were used to evaluate goodness of ﬁt.
RESULTS AND DISCUSSION
Identiﬁcation of the determinants for Tat(44–61)
binding to cTAR
To map the critical amino acids of Tat(44–61) for binding
to cTAR, comparative quantitative afﬁnity measurements
of Tat(44–61) mutants (Figure 1) were assessed using
ﬂuorescence anisotropy by titrating a ﬁxed amount of
cTAR-Fl with increasing peptide concentrations
(Supplementary Figure S1, Supplementary Data). The
values of the observed equilibrium association constants
Kobs for the various peptides were obtained by ﬁtting the
data with Equation (1), assuming that the n=10 binding
sites on TAR DNA were identical and independent. This
approach was shown to be reasonable to comparatively
assess the afﬁnities of other viral proteins and their
mutants with cTAR DNA (30,49,50). The Kobs value of
9(±2) 107M1 obtained for the native Tat(44–61)
peptide was close to the 1.7 108M1 and 5.1 107M1
values (Table 1) reported for slightly shorter peptides,
namely, Tat(47–58) and Tat(46–60), respectively, to their
speciﬁc binding site on the upper part of TAR RNA
(12,51). This similarity in the binding constants clearly
indicates that the Tat(44–61) peptide binds to cTAR
DNA with high afﬁnity, giving further credit to the rele-
vance of cTAR as a target of the Tat protein.
Although replacement of the Tyr47 residue by an Ala
residue in the Tat(44–61)Y47A mutant resulted in a
decrease of the Kobs value by a factor of about three,
nearly no change in afﬁnity accompanied its replacement
with Trp in the Tat(44–61)Y47W mutant, suggesting that
an aromatic residue at position 47 is required to stabilize
the complex, likely through stacking with the bases of
cTAR. Interestingly, removal of the six N-terminal
amino acids [Tat(50–61)] only resulted in a marginal add-
itional decrease of the Kobs value as compared with the
Tat(44–61)Y47A mutant, indicating that the Tyr47
residue plays the most important role in the six
N-terminal residues for stabilizing the complex of
Tat(44–61) with cTAR. As Trp conservatively replaces
Tyr in the Tat(44–61)Y47W mutant, and as Trp ﬂuores-
cence properties are highly sensitive to stacking
interactions with bases (52–54), we investigated the
steady-state and time-resolved ﬂuorescence properties of
the conservative Tat(44–61)Y47W mutant to further char-
acterize the binding mode of the Tyr47 residue with
cTAR.
In the absence of cTAR, the wavelength of the emission
maximum (351 nm) and the quantum yield (0.105)
of Trp47 in Tat(44–61)Y47W were typical of those of
fully solvent-exposed Trp residues in unfolded peptides
(55). This conclusion was further substantiated by the
similarity of the time-resolved ﬂuorescence parameters of
Table 1. Equilibrium association constant for the peptide: cTAR
complexes
Peptide Kobs (M-1)
Tat(44–61) 9±2 107a
Tat(44–61)Y47A 3.5±1 107
Tat(44–61)Y47W 9±2 107
Tat(44–57) 1.2±0.3 108
Tat(50–61) 2.4±0.4 107
Tat(44–61)Q54A 5.7±1 107
Tat(44–61)R52A, R53A 8±2 106
Tat(44–61)R55A, R56A 1.0±0.1 107
Tat(44–61)ac 3.3±1 106
aFrom ref. (30).
Titrations were monitored by ﬂuorescence anisotropy at 20C in 25mM
Tris (pH 7.5), 30mM NaCl and 0.2mM MgCl2, as described in
Supplementary Figure S1, Supplementary Data. The values of the
observed binding constants, Kobs, were calculated by ﬁtting the titra-
tions curves with Equation (6), assuming ten independent and equiva-
lent binding sites per cTAR molecule.
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Tat(44–61)Y47W (Supplementary Table S1 in Supplemen-
tary Materials) with those of N-acetyl tryptophanamide in
buffer (55). Addition of cTAR induced a dramatic 3.2-fold
decrease in the quantum yield, associated with an only
1.37-fold decrease in the mean lifetime. The differential
behavior of these two parameters clearly suggests the
presence of a population of ‘dark’ species, with a
lifetime shorter than the detection limit of our equipment
(& 30 ps) and an 0 amplitude that could be calculated by:
0 ¼ 1 h iT
h iTcTRm
 
ð2Þ
where <>T and <>T-cT are the mean lifetime of Tat(44–
61)Y47W in the absence and presence of cTAR, respect-
ively, and Rm is the ratio of their quantum yields. An 0
value of 0.46 was obtained. In addition, a short-lived
lifetime of 100 ps associated with an amplitude of 0.14
was also observed. Both the short-lived component and
the dark species could be attributed to a stacking inter-
action of Trp47 with the cTAR bases (52–54). According
to the amplitudes of these components, the Trp47 residue
appears to be stacked in 60% of the Tat(44–61)Y47W/
cTAR complexes, so that stacking is the dominant inter-
action mode for this residue. In the remaining 40% of the
complexes, the lifetimes of Trp47 were only slightly
smaller than those of the free peptides, suggesting that
in these populations, the Trp47 residue exhibits only
limited contacts with the cTAR bases.
In contrast to the N-terminal residues, deletion of the
four C-terminal amino acids [Tat(44–57)] induced a
modest increase of the Kobs value, suggesting a marginal
contribution of the 58PPQG61 residues in the binding of
the peptide to cTAR. Similarly, mutation of the Gln54
residue located within the cluster of basic residues to an
Ala was only accompanied by a moderate decrease of Kobs
(< 2-fold), indicating a limited role of this residue in the
binding process. The contribution of the positively
charged and highly conserved basic residues of Tat was
also investigated. Double mutation of pairs of basic
residues (Arg52 and Arg53, Arg55 and Arg56) to Ala
residues or acetylation of Lys50 and Lys51 residues was
accompanied by a 9- to 30-fold decrease of the Kobs value,
indicating a major role of these residues in the stability of
the cTAR/Tat(44–61) complexes. Interestingly, acetyl-
ation of Lys50 and Lys51 resulted in an even stronger
decrease (30-fold) of the binding afﬁnity than substitu-
tion of the (Arg52, Arg53) or (Arg55, Arg56) pairs by Ala
residues, suggesting that in addition to the neutralization
of charges, acetylation may further hinder the binding
through a steric effect of the acetyl groups. Irrespective
of its exact mechanism, acetylation appears efﬁcient to
reduce the afﬁnity of Tat for its nucleic acid target. As
previously described for the interaction with RNAs
(12,33), ionic interactions of the basic residues with the
negatively charged phosphate groups of cTAR may well
explain their role in the stability of the cTAR/Tat(44–61)
complex.
To further evaluate the contribution of ionic inter-
actions to the binding of Tat (44–61) to cTAR, we
analyzed the salt dependence of the Kobs values according
to (56):
logKobs ¼  ðm0 Na+Þlog Na+
 
+logKð1MÞ ð3Þ
where K(1M) is the equilibrium association constant at 1 M
Na+ (which represents the non-ionic contribution to the
interaction), CNa+ is the fraction of cation thermodynam-
ically bound per phosphate group and m0 is the number of
ion pairs between the peptide and the oligonucleotide. As
cTAR contains both single-stranded and double-stranded
regions, we took for  Na+, a value of 0.8, intermediate to
the values reported for single-strand DNA (0.71) and
double-strand DNA (0.88) (56). From the ﬁt with
Equation (3) of the linear dependence of logKobs on
log[Na+], we obtained m0=4.0 and K(1M)=1900M
1
(Figure 2). The m’ value indicated that half of the basic
residues of the Tat(44–61) peptide were involved in the
binding to cTAR, whereas only one basic residue was
involved in the binding of the Tat(46–60) peptide to its
high-afﬁnity binding site on TAR RNA (51). In contrast,
application of Equation (3) to the binding data of Tat(46–
60) to TAR RNA (51) revealed that its K(1M) value was
about two orders of magnitude higher than the K(1M)
value of Tat(44–61) for cTAR. As non-electrostatic inter-
actions are a hallmark for speciﬁc binding (56), it appears
that despite their comparable binding constants at 30mM
NaCl, the multiple binding sites of cTAR for the Tat
peptides are of less speciﬁc nature than the high-afﬁnity
binding site of TAR.
To get further insight in the involvement of Tat(44–61)
basic residues in cTAR binding, we characterized the salt
dependence of Kobs for the Tat(44–61)ac peptide. The
obtained m0 value (2.6) was signiﬁcantly lower than the
value (4.0) for the native peptide, indicating that Lys50
and Lys51 residues contribute to the electrostatic inter-
actions between the native peptide and cTAR. In
contrast, the K(1M) value (2400M
1) being close to that
Figure 2. Salt dependence of the binding of Tat(44–61) and Tat(44–
61)ac to cTAR. The binding experiments were performed by adding
increasing concentrations of Tat(44–61) (closed squares) or Tat(44–
61)ac (open squares) to 10 nM cTAR-3’-Fl in 25mM Tris buffer (pH
7.5), 0.2mM MgCl2 and the NaCl concentrations indicated on the
X-axis. The binding process was monitored by steady-state ﬂuorescence
anisotropy, as described in ‘Materials and Methods’ and
Supplementary Figure S1 in the Supplementary Materials. The
apparent association constant, Kobs, for each titration was obtained
using Equation (1). The solid lines correspond to the ﬁts of the data
points to Equation (3), using the parameters given in the text.
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for the native peptide indicates that Lys50 and Lys51
residues do not signiﬁcantly contribute to non-ionic inter-
actions. Interestingly, the decrease of the m’ value by a
value of <2 for the acetylated derivative, as well as the
stabilization of the Tat(44–61)/cTAR complexes by only
half of the basic residues of the peptide were somewhat in
variance with the fact that replacement of any combin-
ation of two basic residues of Tat(44–61) by Ala
residues strongly decreased the binding constant. This
apparent contradiction suggests that due to the high ﬂexi-
bility of the peptide (57) and the highly heterogeneous
structure of cTAR (that contains double-stranded
regions, a central and an internal loop as well as bulges
and mismatches), different combinations of four basic
residues likely bind to the various cTAR binding sites.
Taken together, our data show that the Tat(44–61)
domain binds to cTAR DNA with an afﬁnity comparable
with that for TAR RNA, suggesting that cTAR DNA is a
likely target for Tat in the viral life cycle. Moreover, the
clear relationship between the positively charged amino
acids of the Tat(44–61) domain and the afﬁnity of the
peptide for cTAR evidenced a major role of electrostatic
interactions in the binding process. A further stabilization
can be achieved by the Tyr47 residue, mainly through
stacking with the DNA bases. Finally, our data suggest
that both the ﬂexible structure of Tat and the redundancy
of basic residues in its (44–61) domain allow Tat to adapt
to a large number of DNA and RNA sequences, and thus
to coat them efﬁciently.
Gel retardation analysis of the binding of Tat(44–61)
derivatives to cTAR
As the anisotropy technique does not allow discriminating
the different species in solution, the binding properties of
Tat(44–61), Tat(44–61)Y47A, Tat(44–57), Tat(50–61),
Tat(44–61)ac and Tat(44–61)R52, R53A to cTAR were
further investigated by gel retardation experiments
(Figure 3). Controls C1 and C2 were used to locate the
position of free cTAR DNA that has been heat-denatured
in water and incubated in the binding buffer, respectively.
The binding of the native Tat(44–61) peptide at a 1:2 ratio
resulted in a decrease of the band of the free peptide to the
beneﬁt of a discrete band and smears with lower mobility
as well as a band (Ag) in the wells that corresponds to high
molecular weight peptide:cTAR complexes (aggregates)
[Figure 3, Tat(44–61), lane 2]. In the latter, the cTAR
molecules were likely largely coated by Tat(44–61) mol-
ecules, giving neutral complexes prone to aggregate. The
discrete band corresponds probably to complexes where a
limited number of Tat peptides are bound to cTAR. These
data conﬁrmed that cTAR contains several binding sites
for Tat(44–61) and that complexes with various levels of
coating by Tat(44–61) coexisted. Finally, at the highest
peptide to nucleotide ratio (2:1), the free cTAR and the
discrete band disappeared completely, so that most
complexes were aggregates [Figure 3, Tat(44–61), lane 4].
Interestingly, the distributions of complexes with the
Tat(44–57) derivative at the various peptide to nucleotide
ratios were close to those of the wild-type peptide.
Nevertheless, at the two lowest peptide to nucleotide
ratios (compare in Figure 3, lanes 1 and 2 of the two
peptides), a higher concentration of complexes as well as
a lower concentration of free cTAR were observed with
the Tat(44–57) derivative, indicating that this peptide
shows a higher afﬁnity to cTAR, as compared with the
wild-type peptide. This higher afﬁnity was also perceived
in the binding parameters (Table 1) from the anisotropy
Figure 3. Gel retardation assays of the binding of the Tat peptides to
cTAR DNA. The cTAR 32P-DNA was incubated in the absence or the
presence of peptide and analyzed by electrophoresis on a 10% poly-
acrylamide gel as described in ‘Materials and Methods’. Lanes C1,
heat-denatured cTAR DNA. Lanes C2, controls without peptide;
lanes 1–4, peptide to nucleotide molar ratios were 1:4, 1:2, 1:1 and
2:1. The high molecular mass peptide:cTAR complexes (aggregates)
are indicated by Ag.
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titrations, but did not appear clearly, due to the rather
large error bars.
In line with the anisotropy data, the binding patterns
obtained with Tat(44–61)Y47A and Tat(50–61) were
similar. In both cases, we observed a progressive accumu-
lation of complexes with intermediate mobility and high
molecular weight complexes with increasing peptide con-
centrations. The afﬁnities of these two peptides for cTAR
were clearly lower than those of the Tat(44–61) and
Tat(44–57) peptides, as the concentrations of the high mo-
lecular weight complexes were much higher for the latter
at the various peptide concentrations. Noticeably, the
discrete band of intermediate mobility suggests an accu-
mulation of a cTAR complex with a given number of Tat
peptides. This observation is in variance with our assump-
tion of identical and independent binding sites in anisot-
ropy data, as this should have led to a distribution of
complexes of various stoichiometries at sub-saturating
concentrations of Tat peptides. Whether this discrete
band corresponds to a cooperative binding of a few Tat
peptides remains an open question.
In full line with their reduced afﬁnities, Tat(44–
61)R52A,R53A and Tat(44–61)ac did only produce
limited amounts of complexes with intermediate mobility
and nearly, no high molecular weight complexes, conﬁrm-
ing the key roles of the basic residues of Tat in its afﬁnity
for cTAR. The absence of high molecular weight
complexes could be due in part to the lower afﬁnity of
these peptides for cTAR, but it is also likely that all
positive charges of the Tat peptide are needed to ensure
the appropriate neutralization of the complexes with
cTAR, and thus allow their aggregation. Moreover, com-
parison of the gels with the two peptides conﬁrmed that
Tat(44–61)ac is of lower afﬁnity than Tat(44–
61)R52A,R53A, as the former only induced a faint
complex of intermediate mobility at the highest peptide
to nucleotide ratio.
Taken together, these observations showed that the
electrophoresis patterns of the various Tat derivatives
are different and correlate well with their binding afﬁnities
determined by ﬂuorescence anisotropy. The Tat deriva-
tives associated with the highest binding constants form
efﬁciently high molecular weight complexes, in which
cTAR molecules are thought to be largely coated by Tat
molecules. Though smears are observed in nearly all lanes,
the discrete bands seen with all peptides suggest that
cTAR molecules coated by a deﬁned number of molecules
can accumulate. The equilibrium between these complexes
and the high molecular mass complexes that cannot enter
the gel appeared ﬁnely tuned by the basic and Tyr residues
of the Tat(44–61) sequence, as enlightened by the signiﬁ-
cant changes in the distribution of the complexes in the
mutational binding pattern analysis.
Analysis of cTAR protection and conformational changes
on interaction with Tat peptides
Next, to further characterize the interaction of the Tat
peptides with cTAR, we investigated the peptide-induced
protection of cTAR to enzymatic digestion to identify the
cTAR nucleotides coated by the peptides. To this end, we
performed a footprinting analysis, using MB nuclease and
DNase I. MB is highly selective for single-stranded se-
quences and domains (58), whereas DNase I is a double-
strand-speciﬁc endonuclease that produces single-strand
nicks (59). The protections induced by Tat(44–61) in the
cTAR hairpin were identiﬁed by comparing the cleavage
patterns of cTAR in the absence and in the presence of
increasing concentrations of Tat(44–61) (Figure 4).
Consistent with the ability of Tat(44–61) to efﬁciently
coat and aggregate the cTAR molecules at high peptide
to nucleotide molar ratios, we observed a complete abol-
ishment of cTAR cleavage by MB (Figure 4A, lanes 4–6)
and DNase I (Figure 4B, lanes 4–6) at peptide to nucleo-
tide ratios 1:2. In contrast, the Tat(44–61)Y47A and
Tat(44–61)ac peptides induced limited and nearly no pro-
tection, respectively, to the enzymes (Figure 4). Thus, the
protection induced by the various peptides correlates well
with their ability to induce high molecular weight
complexes (Figure 3). At the lowest peptide to nucleotide
molar ratios [1:4 for Tat(44–61) and 1:2 for Tat(44–
61)Y47A], only modest changes in the accessibility to MB
were observed at the level of C26 of the apical loop, and C5
of the lower part of the stem (Figure 4A). For DNase I,
moderate but signiﬁcant decreases in the accessibility to
this enzyme were observed at the same peptide to nucleo-
tide molar ratios for positions T4, T7, G9, C10 and A12, in
the double-stranded regions of the lower part of cTAR
(Figure 4B). The moderate protection observed at the
lowest peptide to nucleotide ratios suggests that either
the nucleotides targeted by the two enzymes may not be
included in preferential binding sites for the Tat peptides
or that Tat peptides can be rapidly out-competed by the
enzymes from their binding sites. Moreover, the absence
of additional bands in the presence of the various Tat
peptides likely excludes that the Tat peptides induce
major conformational changes in the cTAR molecules.
Perhaps, the only exception is the signiﬁcant increase in
MB accessibility at the level of the C5 nucleotide, observed
only for the Tat(44–61)Y47A peptide. Together with the
decrease of DNaseI accessibility at the neighbor T4 nu-
cleotide, the change of accessibility of C5 to MB
suggests that Tat(44–61)Y47A may destabilize the penul-
timate double-strand segment of cTAR. However, this de-
stabilization may not extend up to the cTAR termini, as
no destabilization was observed by ﬂuorescence tech-
niques, using the doubly labeled TMR-50-cTAR-30-Fl
(data not shown).
In a next step, we monitored the peptide-induced con-
formational changes of cTAR, using the cTAR Lai
sequence where A residues were substituted by
2-aminopurine (2-Ap), a ﬂuorescent analog of Adenine
(60), at positions 9, 17, 21, 28, 35, 45, 49, 53 and 55
(61). Due to the exquisite sensitivity of 2-Ap ﬂuorescence
to its local environment (62,63), site-speciﬁc characteriza-
tion of the structural modiﬁcations within the cTAR
hairpin sequence can be determined. The Tat(44–61)
peptide induced signiﬁcant changes in the 2-Ap quantum
yield, only at position 9 and 49, where increases of  100
and 200%, respectively, were observed (Supplementary
Figure S2, Supplementary Materials). Nevertheless, these
changes were signiﬁcantly less that those observed with
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NC(11–55) (61), a peptide that corresponds to the zinc-
bound ﬁnger domain of NCp7 and that shows nucleic acid
destabilizing and annealing activities (47,64). In contrast,
the Tat(44–61)-induced changes in 2-Ap quantum yield
were similar to those induced by the unfolded
(SSHS)2NC(11–55) peptide, that acts as a nucleic acid
annealer, being defective in cTAR destabilization (49)
but efﬁcient in promoting cTAR/dTAR annealing (61).
Therefore, by analogy to the (SSHS)2NC(11–55) peptide,
the basic amino acids of Tat(44–61) peptide are thought to
interact mainly through electrostatic interactions with the
DNA phosphate groups, so that the structure of the major
part of cTAR is only marginally affected by Tat(44–61), in
line with the footprinting data. Moreover, the changes in
2-Ap quantum yield at positions 9 and 49 are consistent
with a peptide-induced base tilting, as was reported for
arginine/lysine oligopeptides (65) and Tat(44–61) (33,66)
with other DNA or RNA sequences. As both residues
are in the lower part of the cTAR stem that plays a key
role in cTAR/dTAR annealing (31), the tilting of these
two residues is thought to favor the intermolecular base
pairings required for nucleating the cTAR/dTAR duplex.
Identiﬁcation of the determinants of the nucleic acid
annealing activity of Tat(44–61)
As a preliminary step in the identiﬁcation of the determin-
ants of the Tat(44–61) domain in its nucleic acid annealing
activity during RTion, we investigated whether the
Tat(44–61) peptide is able to direct the annealing of the
TAR RNA and cTAR DNA sequences involved in the
ﬁrst strand transfer. To this end, we used a previously
reported annealing assay based on the ﬂuorescence restor-
ation of a doubly labeled TMR-50-cTAR-30-Fl sequence
(47,67). In contrast to NC(11–55), used as a positive
control (Figure 5, red trace), no signiﬁcant ﬂuorescence
enhancement could be detected during the time course of
the experiment in the presence of 3 molecules of Tat(44–
61) per oligonucleotide, showing that Tat(44–61) was
unable to promote the annealing of TAR RNA to the
doubly labeled cTAR (Figure 5, black trace). The inability
of Tat(44–61) to promote cTAR/TAR annealing was con-
ﬁrmed by gel electrophoresis, using radiolabeled RNA
(data not shown). In contrast, when TAR RNA was
replaced by dTAR, the DNA equivalent of TAR RNA,
the annealing reaction was fully achieved in 1500 s
(Figure 5, green curve). These data can be explained by
the fact that the promotion of TAR/cTAR annealing
involves a critical destabilization step (61) that can be
induced by NC(11–55) (68,69) but not by Tat(44–61)
(31). Moreover, in contrast to TAR, the existence of a
small amount of thermally melted and reactive dTAR at
20C (64,68,70,71) can facilitate its annealing with cTAR,
already in the absence of peptide.(47) As a consequence,
the strong acceleration of the annealing reaction between
cTAR and dTAR but not TAR by Tat(44–61) conﬁrms
that this peptide promotes only annealing reactions that
can already occur in the absence of peptide. Therefore,
Tat(44–61) is conﬁrmed as a nucleic acid annealer rather
than a true chaperone (33).
To investigate the determinants of the nucleic acid an-
nealing properties of Tat(44–61), we characterized the
cTAR/dTAR annealing reaction in the presence of the
various Tat(44–61) mutants. As Tat is probably present
at low concentrations during RTion both in the virus and
the cytosol of infected cells, the annealing reactions were
examined at the low molar ratio value of three peptides
per oligonucleotide. Moreover, this low ratio corresponds
also to aggregation-free conditions (31), which are critical
Figure 4. Footprinting analysis of the complexes of cTAR with Tat peptides using MB nuclease (A) and DNase I (B). Footprinting experiments were
performed as described in ‘Materials and Methods’. The 30-end-labeled cTAR DNA was incubated with MB (2 units) or DNase I (0.1 unit) in the
absence (lanes 1) or in the presence of the peptides (lanes 2–6). The peptide to nucleotide molar ratios were 1:8 (lanes 2), 1:4 (lanes 3), 1:2 (lanes 4)
1:1 (lanes 5) and 2:1 (lanes 6). Lanes C are controls without peptide and endonuclease. The G, G+A and T+C refer to Maxam–Gilbert sequence
markers of cTAR run in parallel to identify the cleavage sites. Arrows indicate the cleavage sites. Closed, gray and open symbols indicate strong,
medium and weak cleavage sites in the absence of peptide, respectively.
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to avoid artifacts in the ﬂuorescence techniques. For all
the tested mutants, we observed a large ﬂuorescence
increase resulting from the conversion of the doubly
labeled cTAR stem-loop to the ﬁnal cTAR/dTAR
duplex (Figure 6). The ﬂuorescence intensity reached a
ﬁnal plateau value in 400–8000 s, depending on the
peptide. The plateau value by itself was not inﬂuenced
by the dTAR concentration or by the peptide nature,
indicating that the doubly labeled cTAR was always
fully converted to an extended duplex (ED) that cannot
be dissociated by the peptides. As cTAR/dTAR annealing
is a long lasting process in the absence of peptide, taking
more than one day at room temperature (47), the kinetic
curves (Figure 6) clearly indicated that all tested peptides
promoted annealing, although with different efﬁciency. As
reported for the Tat(44–61)-directed annealing (30,31), all
traces were best described by a double exponential
function:
IðtÞ ¼ If  ðIf  I0Þðaekobs1ðttoÞ+ð1 aÞekobs2ðttoÞÞ ð4Þ
where I(t) is the ﬂuorescence intensity at time t, kobs1 and
kobs2 are the apparent pseudo ﬁrst-order rate constants
governing the two kinetic components, a is the relative
amplitude of the fast component, and t0 is a dead time.
I0 and If stand for the ﬂuorescence intensities of TMR-5
0-
cTAR-30-Fl in its free form and in the ﬁnal ED, respect-
ively. The If, I0 and t0 were determined independently.
For most of the Tat(44–61) peptides, the fast compo-
nent kobs1 linearly varies with [dTAR], whereas kobs2 shows
a hyperbolic dependence on [dTAR]. This suggests that
the various peptides likely promote the formation of an
intermediate complex (IC) that further converts into the
ﬁnal ED, in a two-step reaction scheme (Scheme 1) similar
to that of the native peptide (31):
where kass is the second-order association rate constant for
the formation of IC, and kdiss and k2 are the ﬁrst-order
rate constants for the dissociation of IC and for its con-
version into ED, respectively. The values of the different
parameters (Table 2) were determined using the Dynaﬁt
numerical resolution software (48), which allows to simul-
taneously ﬁt the experimental progress curves obtained at
different dTAR concentrations. These values were in ex-
cellent agreement with those obtained by ﬁtting the kobs1
and kobs2 dependence on the dTAR concentration (data
not shown), giving good conﬁdence in the retrieved values
and the proposed reaction scheme. Comparison of (i) the
kinetic curves (Figure 6), (ii) the kass, kdiss and k2 values
(Table 2) and iii) the gel electrophoresis data of the
various peptides in cTAR/dTAR annealing (Supplemen-
tary Figure S3, Supplementary Data) clearly revealed the
existence of two classes of peptides. These two classes
could not be related to differences in the number of
bound peptides per oligonucleotide, because based on
the binding data of Table 1 and the experimental condi-
tions used for the annealing experiments, we calculated
that at least 80% of the added peptides were bound in
these experiments. The ﬁrst class, composed of Tat(44–
61), Tat(44–57), Tat(44–61)Y47W and Tat(44–61)Q54A
was characterized by high values for both the kinetic as-
sociation (kass=0.41 1.2 105M1s1) and dissociation
rate constants (kdiss=1.5 – 2.0 102 s1) that were re-
spectively up to 48- and 9-fold higher than the correspond-
ing values of the peptides of the second class [Tat(50–61),
Tat(44–61) R52A,R53A, Tat(44–61) R55A,R56A,
Tat(44–61)ac and Tat(44–61)Y47A]. Thus, efﬁcient
cTAR/dTAR annealing requires the interactions between
the peptide-coated reactants to be highly dynamic.
Interestingly, the kass values of the ﬁrst class of peptides
were comparable with those observed for the NCp7-
promoted cTAR/TAR annealing at nearly saturating
concentrations of NCp7 (72), which likely allow the oligo-
nucleotides to rapidly explore various interaction modes,
Scheme 1. Mechanism for the Tat(44–61)-promoted cTAR/dTAR
annealing.
Figure 6. Kinetics of cTAR/dTAR annealing in the presence of
Tat(44–61) derivatives. The annealing of TMR-50-cTAR-30-FL
(10 nM) with dTAR (500 nM) was monitored in 25mM Tris buffer
(pH 7.5), 0.2mM MgCl2, 30mM NaCl, in the presence of Tat(44–61)
and its various derivatives used at a molar ratio of three peptides per
oligonucleotide. Black trace: Tat(44–61), violet: Tat(44–57), green:
Tat(44–61)Y47A, cyan: Tat(44–61)R52A,R53A, blue: Tat(44–61)R55A,
R56A, red: Tat(44–61)ac and orange: Tat(50–61). The kinetic traces
of Tat(44–61)Q54A and Tat (44–61)Y47W were nearly superimposable
with the Tat(44–61) one, and thus were not represented. The solid lines
correspond to the best ﬁt of the kinetic curves to Equation (4).
Figure 5. Evidence that Tat(44–61) does not promote cTAR/TAR
RNA annealing in vitro. The 10 nM TMR-50-cTAR-30-Fl was reacted
with 100 nM TAR RNA (black trace) or with 100 nM dTAR (green
trace) using a peptide to oligonucleotide molar ratio of 3. For com-
parison, cTAR/TAR RNA annealing was also monitored in the
presence of NC(11–55) at a molar ratio of 11 peptides per oligonucleo-
tide (red trace). The solid lines correspond to the best ﬁt of the kinetic
curves to Equation (4).
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and thus ﬁnd the appropriate one that will nucleate the
ED. Moreover, the high kdiss values likely avoid cTAR
and dTAR to be kinetically trapped in misfolded ICs
that would be unable to lead to the ED. As the full
length Tat was reported to exhibit kinetic rate constants
close to those of Tat(44–61) in promoting the cTAR/
dTAR annealing (31), these highly dynamic interactions
constitute likely also a major component of the annealer
properties of Tat. Noticeably, as the decrease in the kass
values for the second class of peptides as compared with
the ﬁrst class was partly compensated by their decreased
kdiss values, the values of the IC equilibrium constant, Ka,
were comparable for both classes, suggesting that the IC
stability per se does not constitute a key factor in the dif-
ferent annealing properties of the two classes.
Peptides of the ﬁrst class were also characterized by k2
values (1.3–2.2 102 s1) that are 2- to 16-fold higher
than the k2 values of the second class, indicating that they
more efﬁciently convert the IC into the ﬁnal ED.
Moreover, comparison of the kinetic parameters of the
two classes further revealed that the Gln54 residue and
the 58PPQG61 sequence of Tat(44–61) marginally contrib-
ute to the annealing activity of the peptide. In sharp
contrast, both the basic residues and the Tyr47 residue
were critical for efﬁcient cTAR/dTAR annealing by
contributing both to the highly dynamic interaction
between the oligonucleotides and the efﬁcient interconver-
sion of the IC into the ED. Moreover, although replace-
ment of Tyr47 with Ala led to strong changes of the kinetic
parameters, its replacement with Trp preserved the full
activity, indicating that the aromatic nature of the
residue at position 47 is crucial for nucleic acid annealing.
To further dissect the effect of the Tat mutants on the
cTAR/dTAR annealing reaction, we plotted the depend-
ence of the kobs1/2 values on the temperature in the range
5–50C through an Arrhenius plot (Figure 7). According
to the Arrhenius model, the transition state thermo-
dynamic parameters can be derived from the reaction
rates using:
ln k1,2 ¼ Ea
R
 1
T
+lnA ð5Þ
where the rate constant k1/2 is given by kobs1/2/[cTAR], A is
a pre-exponential factor, Ea is the activation energy, R the
universal gas constant and T is the absolute temperature
in Kelvin. Mutations and truncations of the Tat(44–61)
peptide marginally inﬂuenced the slopes of the straight
lines ﬁtted to the data in Figure 7A (fast component)
and 7B (slow component). The values of Ea and the cor-
responding transition state enthalpy DHz (Supplementary
Table S2, Supplementary Materials) showed that the dif-
ferent peptides comparatively inﬂuenced the energy
barriers for the transition states of the cTAR/dTAR an-
nealing reaction. As previously reported (31), the DHz
values of 10 and 18 kcal.mol1 for the fast and slow
components, respectively, indicate that the cTAR/dTAR
annealing promoted by the Tat peptides involves
premelting of 2–3 base pairs for the fast component and
4–5 base pairs for the slow component.
To further delineate the differences between the two
classes of Tat peptides in their ability to promote cTAR/
dTAR annealing, the kass parameter, which is largely re-
sponsible for the different behaviors of the two classes,
was expressed as (73):
kass ¼ kdiffexpðGm=RTÞexpðGnuc=RTÞ ð6Þ
where kdiff (6.5 109M1s1) is the theoretical
diffusional collision rate of annealing molecules (73,74),
whereas exp(Gm/RT) and exp(Gnuc/RT) reﬂects
the probability of the colliding molecules to be in the
melted reactive species and the probability of the collision
to be productive, and thus nucleate the IC, respectively.
As none of the Tat peptides could destabilize the cTAR
termini (data not shown), the probability of the cTAR
termini to be in a melted reactive form was set to the
0.15 value of the equilibrium dissociation constant that
results from thermal fraying (68). From this value and
Equation (6), we deduced for Tat(44–61) and the
peptides of the ﬁrst class, a DGnuc value of 5 kcal.mol1.
This value for the transition free energy for nucleation is
signiﬁcantly smaller than the >7 kcal.mol1 values for the
peptides of the second class, indicating that the peptides
Table 2. Parameters for the cTAR fret/dTAR annealing in the presence of Tat(44–61) and its variants at 20Ca
Parameter Tat(44–61) Tat(44–57) Tat(44–61)
Y47W
Tat(44–61)
Q54A
Tat(50–61) Tat(44–61)
R52A, R53A
Tat(44–61)
R55A, R56A
Tat(44–61)ac Tat(44–61)
Y47A
kass (M
1.s1 105) 1.2b 0.8 1.1 0.41 0.025 0.036 0.031 0.025 0.039
kdiss (s
1 100) 1.6b 2 1.5 1.9 0.38 0.29 0.22 0. 40 0.24
k2 (s
1 100) 1.3b 2.2 1 1.3 0.59 0.13 0.17 0.46 0.56
Ka (M
1 106)c 7.5 4 7.3 2.2 0.66 1.2 1.4 0.65 1.6
Gz (kcal.mol1)d 6.3 6.6 6.4 7 8.6 8.4 8.5 8.6 8.3
G nuc (kcal.mol1)e 5.2 5.5 5.3 5.9 7.5 7.3 7.4 7.5 7.2
Activity in RTionf 100 100 100 30 30 35 20
aThe annealing reactions were performed as described in Figure 6. The values of the kinetic parameters, kass, kdiss and k2 were calculated by Dynaﬁt
from the experimental progress curves on the basis of a two-step mechanism.
bValues from (31).
ckass/kdiss ratio.
dcalculated using DGz=RTln(kass/kdiff) with kdiff = 6.5 109M1s1.70.
eDGnuc values were calculated from Equation (5).
fValues are from Figure 2 of reference (42).
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from the ﬁrst class substantially increase the probability of
productive collisions for nucleating the IC. These efﬁcient
productive collisions likely result from the ability of the
basic residues of Tat(44–61) to efﬁciently screen the nega-
tively charged cTAR and dTAR sequences and create
short range interactions between them, as well as from
the base tilting promoted by Tyr47 stacking that
probably favors intermolecular base pairing between the
complementary sequences.
Finally, our objective was to correlate our kinetic and
thermodynamic data with previously reported RTion data
obtained using HIV-1 viruses prepared from cell lines ex-
pressing HIV-1 Dtat viruses (in which the tat gene has
been functionally deleted) and stably transcomplemented
with wild-type or mutant Tat proteins (42). The ability of
these Tat proteins to restore RTion in HIV-1 Dtat viruses
was evaluated in natural endogenous RTion assays,
comparing HIV-1 viruses transcomplemented with Tat
proteins mutated in the (44–57) domain relatively to
viruses transcomplemented with the wild-type Tat
protein. Interestingly, a perfect correlation was observed
between the efﬁciency of Tat mutants to promote RTion
and their ability to promote fast association and dissoci-
ation of the IC (Table 2). A dramatic decrease in RTion
efﬁciency was seen with mutation of Tyr47 in Ala
and replacement of pairs of basic residues by Ala,
whereas in contrast, replacement of Gln54 with Ala or re-
placement of Tyr47 with Trp had no effect on Tat-
promoted RTion.
Taken together, our data show that the efﬁciency of the
Tat peptides to promote cTAR/dTAR annealing is
associated with their ability to favor highly dynamic inter-
actions between the complementary oligonucleotides to
nucleate the IC. Moreover, the ability of a given Tat
mutant to promote these dynamic interactions closely
correlates with its ability to promote RTion, suggesting
that it constitutes a key feature of the annealer properties
of Tat.
CONCLUSION
In this work, we showed that the basic (44–61) domain of
Tat binds to cTAR DNA with an afﬁnity comparable with
that for TAR RNA, suggesting that cTAR DNA is a
likely target for Tat in the viral life cycle. This strong
binding afﬁnity was found to be mediated through elec-
trostatic interactions between on the average 4 of the 8
basic residues of the Tat(44–61) domain and the DNA
phosphate groups as well as through a stacking of the
Tyr47 residue with the DNA bases. Interestingly, our
data further suggest that both the high ﬂexibility of Tat
and the presence of more basic residues than needed for
tight binding enable Tat to bind to nearly any nucleic acid
sequence, by adjusting its structure and selecting the most
appropriate combination of basic residues. Moreover, the
Tat basic domain was found to induce only limited con-
formational changes in cTAR, with the exception of nu-
cleotides in the lower part of the cTAR stem that are
thought to be tilted by the Tat(44–61) domain, and thus
become annealing competent. As similar observations
were reported for the binding of the ﬁngerless and
unfolded (SSHS)2NC(11–55) derivative to cTAR (61)
and for the binding of the basic domains of the core
protein of the Hepatitis C virus to its nucleic acid
targets (75), it is likely that these basic nucleic acid an-
nealers share common binding modes and mechanisms.
One major aspect of this work is the demonstration that
efﬁcient cTAR/dTAR annealing requires highly dynamic
interactions between the peptide-coated oligonucleotides,
probably to efﬁciently nucleate the IC and prevent
trapping of misfolded intermediates. As the Tat(44–61)
peptide and the full-length Tat protein induce similar
cTAT/dTAR kinetics, these highly dynamic interactions
are believed to be also promoted by the native Tat
protein and constitute a general property of basic
nucleic acid annealers. Structure–activity relationship
studies further indicated that these dynamic interactions
are supported by the basic residues and the Tyr47 residue
of the (44–61) domain, and that they correlate well with
the ability of Tat to promote RTion (42). As annealing
between complementary DNA sequences occurs during
the late steps of RTion, our data suggest that Tat may
intervene as a nucleic acid annealer role in these late
steps. This conclusion is in line with the much higher
Figure 7. Arrhenius analysis of the annealing of cTAR to dTAR in the
presence of Tat (44–61) derivatives. Temperature dependence of kobs1
(A) and kobs2 (B) for the reaction of 10 nM TMR-5
0-cTAR-30-FL with
100 nM dTAR in the presence of Tat(44–61) (black), Tat(44–61)Q54A
(gray), Tat(44–57) (magenta), Tat(44–61)Y47A (green), Tat(44–
61)R52A,R53A (cyan), Tat R55A,R56A (blue), Tat(50–61) (orange)
or Tat(44–61) acetylated (red). The straight lines represent the best
ﬁts of the data to Equation (5).
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(30-fold) defect in the synthesis of full-length DNA as
compared with the ﬁrst strand (10-fold) observed with
Dtat HIV-1 virions deleted of the tat gene (22), indicating
a probable role of Tat during the late steps of RTion.
Moreover, due to its signiﬁcantly lower afﬁnity for
double-stranded DNA as compared with single-stranded
DNA and RNA (76), NCp7, the major nucleic acid chap-
erone in RTion is thought to partially dissociate from the
nucleic acids during the late steps of RTion (77–79), so
that Tat may partly replace NC during these late steps.
This hypothesis is further reinforced by the fact that the
two proteins were shown to not only exhibit comparable
annealing activities but also to act synergistically (31).
Thus, together with the likely dissociation of NC from
double-stranded DNA due to its low afﬁnity for this sub-
strate, the synergistic annealing activity of the two
proteins reinforces the hypothesis that Tat may play a
major role in the presence of residual NC molecules
during the late steps of RTion. Furthermore, our data
indicate that the Tat(44–61) peptide is unable to
promote the annealing of cTAR with TAR RNA that
occurs during the ﬁrst obligatory strand transfer of
RTion. Again, these data are consistent with the fact
that similar defects were observed for the synthesis of
the ﬁrst strand and the () strong stop DNA with Dtat
HIV-1 virions, indicating that in contrast to NCp7 [for
review, see refs (69,80,81)], Tat probably plays a
marginal role in the ﬁrst strand transfer. The inability of
the Tat(44–61) peptide to promote cTAR/TAR annealing
is reminiscent of the poor efﬁciency of the (SSHS)2NC(11–
55) peptide to promote the same reaction (61), suggesting
that the absence of nucleic acid destabilizing component in
annealers likely prevents them to promote annealing reac-
tions involving stable sequences, such as TAR RNA.
Moreover, as single-point mutations of the Tyr47
residue were shown to be unable to affect the activity of
Tat in transcription of the integrated HIV viral genome
(42) as well as the ability of the Tat basic domain to
promote the annealing of two short single-stranded
RNA sequences (33), it is believed that Tat exhibits dif-
ferent interaction modes and mechanisms on RNA and
DNA sequences. Finally, the efﬁcient decrease in the
binding afﬁnity to cTAR and the strong decrease in the
Tat-promoted cTAR/dTAR kinetics induced by acetyl-
ation of Lys50 and Lys51 residues indicate that this
in vivo post-translational modiﬁcation of Tat (34,82)
may efﬁciently down-regulate the role of Tat in RTion.
As active Tat peptides are responsible for highly
dynamic interactions between oligonucleotides, it is
likely that these peptides have to be in fast and transient
equilibrium with their target nucleic acids as well. Such a
fast nucleic acid binding and dissociation was described
for NCp7, and shown to be a key component of the
nucleic acid chaperone properties of this protein (83).
Moreover, by analogy to the Tat(44–61) peptide, the
aromatic residues of NCp7 were found essential in these
fast kinetics (84). Thus, it may be speculated that this
rapid binding and dissociation may also be a hallmark
of Tat(44–61), in particular, and nucleic acid annealers,
in general. This point is under current investigation.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online,
including [85–87].
ACKNOWLEDGEMENTS
The authors acknowledge Anny Wund, Fanny Courte,
Roman Storchak, Pauline Re´my and Florian Moser for
their technical help.
FUNDING
Agence Nationale de la Recherche [ANR-10-BLAN-1529
to Y. M.] and Agence Nationale de Recherches sur le Sida
et les he´patites virales (to O. M., J. G. and Y. M.).
Funding for open access charges: Centre National de la
Recherche Scientiﬁque (CNRS) and University of
Strasbourg.
Conﬂict of interest statement. None declared.
REFERENCES
1. Nabel,G. and Baltimore,D. (1987) An inducible transcription
factor activates expression of human immunodeﬁciency virus in T
cells. Nature, 326, 711–713.
2. Berkhout,B., Silverman,R.H. and Jeang,K.T. (1989) Tat trans-
activates the human immunodeﬁciency virus through a nascent
RNA target. Cell, 59, 273–282.
3. Feng,S. and Holland,E.C. (1988) HIV-1 tat trans-activation
requires the loop sequence within tar. Nature, 334, 165–167.
4. Weeks,K.M., Ampe,C., Schultz,S.C., Steitz,T.A. and
Crothers,D.M. (1990) Fragments of the HIV-1 Tat protein
speciﬁcally bind TAR RNA. Science, 249, 1281–1285.
5. Churcher,M.J., Lamont,C., Hamy,F., Dingwall,C., Green,S.M.,
Lowe,A.D., Butler,J.G., Gait,M.J. and Karn,J. (1993) High
afﬁnity binding of TAR RNA by the human immunodeﬁciency
virus type-1 tat protein requires base-pairs in the RNA stem and
amino acid residues ﬂanking the basic region. J. Mol. Biol., 230,
90–110.
6. Jones,K.A. (1989) HIV trans-activation and transcription control
mechanisms. New Biol., 1, 127–135.
7. Jones,K.A. and Peterlin,B.M. (1994) Control of RNA initiation
and elongation at the HIV-1 promoter. Annu. Rev. Biochem., 63,
717–743.
8. Jeang,K.T. (1998) Tat, Tat-associated kinase, and transcription.
J. Biomed. Sci., 5, 24–27.
9. Jeang,K.T., Xiao,H. and Rich,E.A. (1999) Multifaceted activities
of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem.,
274, 28837–28840.
10. Karn,J. (1999) Tackling tat. J. Mol. Biol., 293, 235–254.
11. Selby,M.J. and Peterlin,B.M. (1990) Trans-activation by HIV-1
Tat via a heterologous RNA binding protein. Cell, 62, 769–776.
12. Calnan,B.J., Biancalana,S., Hudson,D. and Frankel,A.D. (1991)
Analysis of arginine-rich peptides from the HIV Tat protein
reveals unusual features of RNA-protein recognition. Genes Dev.,
5, 201–210.
13. Weiss,M.A. and Narayana,N. (1998) RNA recognition by
arginine-rich peptide motifs. Biopolymers, 48, 167–180.
14. Puglisi,J.D., Chen,L., Frankel,A.D. and Williamson,J.R. (1993)
Role of RNA structure in arginine recognition of TAR RNA.
Proc. Natl Acad. Sci. USA, 90, 3680–3684.
15. Calnan,B.J., Tidor,B., Biancalana,S., Hudson,D. and
Frankel,A.D. (1991) Arginine-mediated RNA recognition: the
arginine fork. Science, 252, 1167–1171.
16. Meredith,L.W., Sivakumaran,H., Major,L., Suhrbier,A. and
Harrich,D. (2009) Potent inhibition of HIV-1 replication by a Tat
mutant. PLoS One, 4, e7769.
1076 Nucleic Acids Research, 2014, Vol. 42, No. 2
Downloaded from https://academic.oup.com/nar/article-abstract/42/2/1065/1026599
by SCD U.Louis Pasteur - Section Médecine user
on 06 February 2018
17. Chiu,Y.L., Ho,C.K., Saha,N., Schwer,B., Shuman,S. and
Rana,T.M. (2002) Tat stimulates cotranscriptional capping of
HIV mRNA. Mol. Cell, 10, 585–597.
18. Berro,R., Kehn,K., de la Fuente,C., Pumfery,A., Adair,R.,
Wade,J., Colberg-Poley,A.M., Hiscott,J. and Kashanchi,F. (2006)
Acetylated Tat regulates human immunodeﬁciency virus type 1
splicing through its interaction with the splicing regulator p32.
J. Virol., 80, 3189–3204.
19. Charnay,N., Ivanyi-Nagy,R., Soto-Rifo,R., Ohlmann,T., Lo´pez-
Lastra,M. and Darlix,J.-L. (2009) Mechanism of HIV-1 Tat
RNA translation and its activation by the Tat protein.
Retrovirology, 6, 74.
20. Bennasser,Y. and Jeang,K.-T. (2006) HIV-1 Tat interaction with
Dicer: requirement for RNA. Retrovirology, 3, 95.
21. Bennasser,Y., Le,S.-Y., Benkirane,M. and Jeang,K.-T. (2005)
Evidence that HIV-1 encodes an siRNA and a suppressor of
RNA silencing. Immunity, 22, 607–619.
22. Harrich,D., Ulich,C., Garcı´a-Martı´nez,L.F. and Gaynor,R.B.
(1997) Tat is required for efﬁcient HIV-1 reverse transcription.
EMBO J., 16, 1224–1235.
23. Ulich,C., Dunne,A., Parry,E., Hooker,C.W., Gaynor,R.B. and
Harrich,D. (1999) Functional domains of Tat required for
efﬁcient human immunodeﬁciency virus type 1 reverse
transcription. J. Virol., 73, 2499–2508.
24. Apolloni,A., Meredith,L.W., Suhrbier,A., Kiernan,R. and
Harrich,D. (2007) The HIV-1 Tat protein stimulates reverse
transcription in vitro. Curr. HIV Res., 5, 473–483.
25. Chertova,E., Chertov,O., Coren,L.V., Roser,J.D., Trubey,C.M.,
Bess,J.W. Jr, Sowder,R.C. 2nd, Barsov,E., Hood,B.L., Fisher,R.J.
et al. (2006) Proteomic and biochemical analysis of puriﬁed
human immunodeﬁciency virus type 1 produced from infected
monocyte-derived macrophages. J. Virol., 80, 9039–9052.
26. Lori,F., di Marzo Veronese,F., de Vico,A.L., Lusso,P.,
Reitz,M.S. Jr and Gallo,R.C. (1992) Viral DNA carried by
human immunodeﬁciency virus type 1 virions. J. Virol., 66,
5067–5074.
27. Zhang,H., Dornadula,G. and Pomerantz,R.J. (1998) Natural
endogenous reverse transcription of HIV-1. J. Reprod. Immunol.,
41, 255–260.
28. Zhang,H., Dornadula,G. and Pomerantz,R.J. (1996) Endogenous
reverse transcription of human immunodeﬁciency virus type 1 in
physiological microenviroments: an important stage for viral
infection of nondividing cells. J. Virol, 70, 2809–2824.
29. Kameoka,M., Morgan,M., Binette,M., Russell,R.S., Rong,L.,
Guo,X., Mouland,A., Kleiman,L., Liang,C. and Wainberg,M.A.
(2002) The Tat protein of human immunodeﬁciency virus type 1
(HIV-1) can promote placement of tRNA primer onto viral RNA
and suppress later DNA polymerization in HIV-1 reverse
transcription. J. Virol., 76, 3637–3645.
30. Kuciak,M., Gabus,C., Ivanyi-Nagy,R., Semrad,K., Storchak,R.,
Chaloin,O., Muller,S., Me´ly,Y. and Darlix,J.L. (2008) The HIV-1
transcriptional activator Tat has potent nucleic acid chaperoning
activities in vitro. Nucleic Acids Res, 36, 3389–3400.
31. Boudier,C., Storchak,R., Sharma,K.K., Didier,P., Follenius-
Wund,A., Muller,S., Darlix,J.L. and Me´ly,Y. (2010) The
mechanism of HIV-1 Tat-directed nucleic acid annealing supports
its role in reverse transcription. J. Mol. Biol., 400, 487–501.
32. Godet,J., Boudier,C., Humbert,N., Ivanyi-Nagy,R., Darlix,J.-L.
and Me´ly,Y. (2012) Comparative nucleic acid chaperone
properties of the nucleocapsid protein NCp7 and Tat protein of
HIV-1. Virus Res., 169, 349–360.
33. Doetsch,M., Fu¨rtig,B., Gstrein,T., Stampﬂ,S. and Schroeder,R.
(2011) The RNA annealing mechanism of the HIV-1 Tat peptide:
conversion of the RNA into an annealing-competent
conformation. Nucleic Acids Res., 39, 4405–4418.
34. Kiernan,R.E., Vanhulle,C., Schiltz,L., Adam,E., Xiao,H.,
Maudoux,F., Calomme,C., Burny,A., Nakatani,Y., Jeang,K.T.
et al. (1999) HIV-1 tat transcriptional activity is regulated by
acetylation. EMBO J., 18, 6106–6118.
35. Kaehlcke,K., Dorr,A., Hetzer-Egger,C., Kiermer,V., Henklein,P.,
Schnoelzer,M., Loret,E., Cole,P.A., Verdin,E. and Ott,M. (2003)
Acetylation of Tat deﬁnes a cyclinT1-independent step in HIV
transactivation. Mol. Cell, 12, 167–176.
36. Col,E., Caron,C., Seigneurin-Berny,D., Gracia,J., Favier,A. and
Khochbin,S. (2001) The histone acetyltransferase, hGCN5,
interacts with and acetylates the HIV transactivator. Tat. J. Biol.
Chem., 276, 28179–28184.
37. Ott,M., Schno¨lzer,M., Garnica,J., Fischle,W., Emiliani,S.,
Rackwitz,H.R. and Verdin,E. (1999) Acetylation of the HIV-1
Tat protein by p300 is important for its transcriptional activity.
Curr. Biol., 9, 1489–1492.
38. Deng,L., de la Fuente,C., Fu,P., Wang,L., Donnelly,R.,
Wade,J.D., Lambert,P., Li,H., Lee,C.G. and Kashanchi,F. (2000)
Acetylation of HIV-1 Tat by CBP/P300 increases transcription of
integrated HIV-1 genome and enhances binding to core histones.
Virology, 277, 278–295.
39. Benkirane,M., Chun,R.F., Xiao,H., Ogryzko,V.V., Howard,B.H.,
Nakatani,Y. and Jeang,K.T. (1998) Activation of integrated
provirus requires histone acetyltransferase. p300 and P/CAF are
coactivators for HIV-1 Tat. J. Biol. Chem., 273, 24898–24905.
40. Verhoef,K., Koper,M. and Berkhout,B. (1997) Determination of
the minimal amount of Tat activity required for human
immunodeﬁciency virus type 1 replication. Virology, 237, 228–236.
41. Hooker,C.W., Scott,J., Apolloni,A., Parry,E. and Harrich,D.
(2002) Human immunodeﬁciency virus type 1 reverse transcription
is stimulated by tat from other lentiviruses. Virology, 300,
226–235.
42. Apolloni,A., Hooker,C.W., Mak,J. and Harrich,D. (2003) Human
immunodeﬁciency virus type 1 protease regulation of tat activity
is essential for efﬁcient reverse transcription and replication.
J. Virol., 77, 9912–9921.
43. De Rocquigny,H., Ficheux,D., Gabus,C., Fournie´-Zaluski,M.C.,
Darlix,J.L. and Roques,B.P. (1991) First large scale chemical
synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7
in an active form. Biochem. Biophys. Res. Commun., 180,
1010–1018.
44. Kuipers,B.J.H. and Gruppen,H. (2007) Prediction of molar
extinction coefﬁcients of proteins and peptides using UV
absorption of the constituent amino acids at 214 nm to enable
quantitative reverse phase high-performance liquid
chromatography-mass spectrometry analysis. J. Agric. Food
Chem., 55, 5445–5451.
45. Kanevsky,I., Chaminade,F., Chen,Y., Godet,J., Rene´,B.,
Darlix,J.L., Me´ly,Y., Mauffret,O. and Fosse´,P. (2011) Structural
determinants of TAR RNA-DNA annealing in the absence and
presence of HIV-1 nucleocapsid protein. Nucleic Acids Res., 39,
8148–8162.
46. Maxam,A.M. and Gilbert,W. (1980) Sequencing end-labeled DNA
with base-speciﬁc chemical cleavages. Meth. Enzymol., 65,
499–560.
47. Godet,J., de Rocquigny,H., Raja,C., Glasser,N., Ficheux,D.,
Darlix,J.L. and Me´ly,Y. (2006) During the early phase of HIV-1
DNA synthesis, nucleocapsid protein directs hybridization of the
TAR complementary sequences via the ends of their double-
stranded stem. J. Mol. Biol., 356, 1180–1192.
48. Kuzmic,P. (2009) DynaFit—a software package for enzymology.
Meth. Enzymol., 467, 247–280.
49. Beltz,H., Clauss,C., Pie´mont,E., Ficheux,D., Gorelick,R.J.,
Roques,B., Gabus,C., Darlix,J.L., de Rocquigny,H. and Me´ly,Y.
(2005) Structural determinants of HIV-1 nucleocapsid protein for
cTAR DNA binding and destabilization, and correlation with
inhibition of self-primed DNA synthesis. J. Mol. Biol, 348,
1113–1126.
50. Egele´,C., Pie´mont,E., Didier,P., Ficheux,D., Roques,B.,
Darlix,J.L., de Rocquigny,H. and Me´ly,Y. (2007) The single-
ﬁnger nucleocapsid protein of moloney murine leukemia virus
binds and destabilizes the TAR sequences of HIV-1 but does not
promote efﬁciently their annealing. Biochemistry, 46, 14650–14662.
51. Suryawanshi,H., Sabharwal,H. and Maiti,S. (2010)
Thermodynamics of peptide-RNA recognition: the binding of a
Tat peptide to TAR RNA. J. Phys. Chem. B, 114, 11155–11163.
52. Montenay-Garestier,T. and He´le`ne,C. (1968) Molecular
interactions between tryptophan and nucleic acid components in
frozen aqueous solutions. Nature, 217, 844–845.
53. Me´ly,Y., Pie´mont,E., Sorinas-Jimeno,M., de Rocquigny,H.,
Jullian,N., Morellet,N., Roques,B.P. and Ge´rard,D. (1993)
Structural and dynamic characterization of the aromatic amino
Nucleic Acids Research, 2014, Vol. 42, No. 2 1077
Downloaded from https://academic.oup.com/nar/article-abstract/42/2/1065/1026599
by SCD U.Louis Pasteur - Section Médecine user
on 06 February 2018
acids of the human immunodeﬁciency virus type I nucleocapsid
protein zinc ﬁngers and their involvement in heterologous
tRNA(Phe) binding: a steady-state and time-resolved ﬂuorescence
study. Biophys. J., 65, 1513–1522.
54. Bombarda,E., Ababou,A., Vuilleumier,C., Ge´rard,D.,
Roques,B.P., Pie´mont,E. and Me´ly,Y. (1999) Time-resolved
ﬂuorescence investigation of the human immunodeﬁciency virus
type 1 nucleocapsid protein: inﬂuence of the binding of nucleic
acids. Biophys. J., 76, 1561–1570.
55. Lakowicz,J.R. (2006) Principles of Fluorescence Spectroscopy.
Springer, Science + Business Media LLC, New York.
56. Record,M.T. Jr, Lohman,M.L. and De Haseth,P. (1976) Ion
effects on ligand-nucleic acid interactions. J. Mol. Biol., 107,
145–158.
57. Shojania,S. and O’Neil,J.D. (2006) HIV-1 Tat is a natively
unfolded protein: the solution conformation and dynamics of
reduced HIV-1 Tat-(1-72) by NMR spectroscopy. J. Biol. Chem.,
281, 8347–8356.
58. Desai,N.A. and Shankar,V. (2003) Single-strand-speciﬁc nucleases.
FEMS Microbiol. Rev., 26, 457–491.
59. Hampshire,A.J., Rusling,D.A., Broughton-Head,V.J. and
Fox,K.R. (2007) Footprinting: a method for determining the
sequence selectivity, afﬁnity and kinetics of DNA-binding ligands.
Methods, 42, 128–140.
60. Ward,D.C., Reich,E. and Stryer,L. (1969) Fluorescence studies of
nucleotides and polynucleotides. I. Formycin, 2-aminopurine
riboside, 2,6-diaminopurine riboside, and their derivatives. J. Biol.
Chem., 244, 1228–1237.
61. Godet,J., Kenfack,C., Przybilla,F., Richert,L., Duportail,G. and
Me´ly,Y. (2013) Site-selective probing of cTAR destabilization
highlights the necessary plasticity of the HIV-1 nucleocapsid
protein to chaperone the ﬁrst strand transfer. Nucleic Acids Res.,
41, 5036–5048.
62. Jean,J.M. and Hall,K.B. (2001) 2-Aminopurine ﬂuorescence
quenching and lifetimes: role of base stacking. Proc. Natl Acad.
Sci. USA, 98, 37–41.
63. Guest,C.R., Hochstrasser,R.A., Sowers,L.C. and Millar,D.P.
(1991) Dynamics of mismatched base pairs in DNA. Biochemistry,
30, 3271–3279.
64. Bernacchi,S., Stoylov,S., Pie´mont,E., Ficheux,D., Roques,B.P.,
Darlix,J.L. and Me´ly,Y. (2002) HIV-1 nucleocapsid protein
activates transient melting of least stable parts of the secondary
structure of TAR and its complementary sequence. J. Mol. Biol.,
317, 385–399.
65. Helene,C. and Maurizot,J.C. (1981) Interactions of oligopeptides
with nucleic acids. CRC Crit. Rev. Biochem., 10, 213–258.
66. Doetsch,M., Schroeder,R. and Fu¨rtig,B. (2011) Transient RNA-
protein interactions in RNA folding. FEBS J., 278, 1634–1642.
67. Bernacchi,S., Pie´mont,E., Potier,N., van Dorsselaer,A. and
Me´ly,Y. (2003) Excitonic heterodimer formation in an HIV-1
oligonucleotide labeled with a donor-acceptor pair used for
ﬂuorescence resonance energy transfer. Biophys. J., 84, 643–654.
68. Azoulay,J., Clamme,J.P., Darlix,J.L., Roques,B.P. and Me´ly,Y.
(2003) Destabilization of the HIV-1 complementary sequence of
TAR by the nucleocapsid protein through activation of
conformational ﬂuctuations. J. Mol. Biol., 326, 691–700.
69. Godet,J. and Me´ly,Y. (2010) Biophysical studies of the nucleic
acid chaperone properties of the HIV-1 nucleocapsid protein.
RNA Biol., 7, 687–699.
70. Beltz,H., Azoulay,J., Bernacchi,S., Clamme,J.-P., Ficheux,D.,
Roques,B., Darlix,J.L. and Me´ly,Y. (2003) Impact of the terminal
bulges of HIV-1 cTAR DNA on its stability and the destabilizing
activity of the nucleocapsid protein NCp7. J. Mol. Biol., 328,
95–108.
71. Cosa,G., Harbron,E.J., Zeng,Y., Liu,H.W., O’Connor,D.B., Eta-
Hosokawa,C., Musier-Forsyth,K. and Barbara,P.F. (2004)
Secondary structure and secondary structure dynamics of DNA
hairpins complexed with HIV-1 NC protein. Biophys. J., 87,
2759–2767.
72. Vo,M.-N., Barany,G., Rouzina,I. and Musier-Forsyth,K. (2009)
HIV-1 nucleocapsid protein switches the pathway of
transactivation response element RNA/DNA annealing from
loop-loop ‘kissing’ to ‘zipper’. J. Mol. Biol., 386, 789–801.
73. Hargittai,M.R.S., Gorelick,R.J., Rouzina,I. and Musier-
Forsyth,K. (2004) Mechanistic insights into the kinetics of HIV-1
nucleocapsid protein-facilitated tRNA annealing to the primer
binding site. J. Mol. Biol., 337, 951–968.
74. Bloomﬁeld,V.A., Crothers,D.M. and Tinoco,I. (2000) Nucleic
Acids: Structures, Properties, and Functions. University Science
Books, Sausalito, CA.
75. Sharma,K. kant, Didier,P., Darlix,J.L., de Rocquigny,H.,
Bensikaddour,H., Lavergne,J.P., Pe´nin,F., Lessinger,J.M. and
Me´ly,Y. (2010) Kinetic analysis of the nucleic acid chaperone
activity of the hepatitis C virus core protein. Nucleic Acids Res.,
38, 3632–3642.
76. Darlix,J.L., Godet,J., Ivanyi-Nagy,R., Fosse´,P., Mauffret,O. and
Me´ly,Y. (2011) Flexible nature and speciﬁc functions of the HIV-
1 nucleocapsid protein. J. Mol. Biol., 410, 565–581.
77. Mirambeau,G., Lyonnais,S., Coulaud,D., Hameau,L., Lafosse,S.,
Jeusset,J., Borde,I., Reboud-Ravaux,M., Restle,T., Gorelick,R.J.
et al. (2007) HIV-1 protease and reverse transcriptase control the
architecture of their nucleocapsid partner. PLoS One, 2, e669.
78. Mirambeau,G., Lyonnais,S. and Gorelick,R.J. (2010) Features,
processing states, and heterologous protein interactions in the
modulation of the retroviral nucleocapsid protein function. RNA
Biol., 7, 85–95.
79. Lyonnais,S., Gorelick,R.J., Heniche-Boukhalfa,F., Bouaziz,S.,
Parissi,V., Mouscadet,J.F., Restle,T., Gatell,J.M., Le Cam,E. and
Mirambeau,G. (2013) A protein ballet around the viral genome
orchestrated by HIV-1 reverse transcriptase leads to an
architectural switch: from nucleocapsid-condensed RNA to Vpr-
bridged DNA. Virus Res., 171, 287–303.
80. Thomas,J.A. and Gorelick,R.J. (2008) Nucleocapsid protein
function in early infection processes. Virus Res., 134, 39–63.
81. Levin,J.G., Mitra,M., Mascarenhas,A. and Musier-Forsyth,K.
(2010) Role of HIV-1 nucleocapsid protein in HIV-1 reverse
transcription. RNA Biol., 7, 754–774.
82. Bre`s,V., Tagami,H., Pe´lopone`se,J.M., Loret,E., Jeang,K.T.,
Nakatani,Y., Emiliani,S., Benkirane,M. and Kiernan,R.E. (2002)
Differential acetylation of Tat coordinates its interaction with the
co-activators cyclin T1 and PCAF. EMBO J., 21, 6811–6819.
83. Cruceanu,M., Gorelick,R.J., Musier-Forsyth,K., Rouzina,I. and
Williams,M.C. (2006) Rapid kinetics of protein-nucleic acid
interaction is a major component of HIV-1 nucleocapsid protein’s
nucleic acid chaperone function. J. Mol. Biol., 363, 867–877.
84. Wu,H., Mitra,M., McCauley,M.J., Thomas,J.A., Rouzina,I.,
Musier-Forsyth,K., Williams,M.C. and Gorelick,R.J. (2013)
Aromatic residue mutations reveal direct correlation between
HIV-1 nucleocapsid protein’s nucleic acid chaperone activity and
retroviral replication. Virus Res., 171, 263–277.
85. Godet,J., Ramalanjaona,N., Sharma,K.K., Richert,L., de
Rocquigny,H., Darlix,J.L., Duportail,G. and Me´ly,Y. (2011)
Speciﬁc implications of the HIV-1 nucleocapsid zinc ﬁngers in the
annealing of the primer binding site complementary sequences
during the obligatory plus strand transfer. Nucleic Acids Res., 39,
6633–6645.
86. Livesey,A.K. and Brochon,J.C. (1987) Analyzing the distribution
of decay constants in pulse-ﬂuorimetry using the maximum
entropy method. Biophys. J., 52, 693–706.
87. Brochon,J.C. (1994) Maximum entropy method of data analysis
in time-resolved spectroscopy. Meth. Enzymol., 240, 262–311.
1078 Nucleic Acids Research, 2014, Vol. 42, No. 2
Downloaded from https://academic.oup.com/nar/article-abstract/42/2/1065/1026599
by SCD U.Louis Pasteur - Section Médecine user
on 06 February 2018
